Soluble LR11 competes with amyloid β in binding to cerebrospinal fluid?high-density lipoprotein
Soluble LR11 competes with amyloid β in binding to cerebrospinal fluid?high-density lipoprotein
复制标题
可溶性LR11与β淀粉样蛋白竞争与脑脊液高密度脂蛋白的结合
DOI:
10.1016/j.cca.2018.11.024
复制
发表时间:
2019
影响因子:
5
通讯作者:
Miida Takashi
中科院分区:
文献类型:
--
作者:
Yano Kouji;Hirayama Satoshi;Misawa Naomi;Furuta Ayaka;Ueno Tsuyoshi;Motoi Yumiko;Seino Utako;Ebinuma Hiroyuki;Ikeuchi Takeshi;Schneider Wolfgang J.;Bujo Hideaki;Miida Takashi
BackgroundLR11 is a member of the low-density lipoprotein (LDL) receptor family with high expression in neurons. Some cell surface LR11 is cleaved and secreted into the cerebrospinal fluid (CSF) as soluble LR11 (sLR11). Patients with Alzheimer's disease (AD), particularly apolipoprotein E4 carriers, have high CSF–sLR11 and low CSF–amyloid β (Aβ) concentrations. Therefore, we assessed whether sLR11 is bound to CSF–high-density lipoprotein (HDL) and whether sLR11 competes with Aβ in binding to apoE in CSF–HDL.MethodsWe measured CSF–sLR11 concentrations (50 controls and 16 patients with AD) using enzyme immunoassay. sLR11 and apoE distribution in the CSF was evaluated using non-denaturing two-dimensional gel electrophoresis (N–2DGE). ApoE bound to sLR11 or Aβ was identified using co-immunoprecipitation assay.ResultsCSF–sLR11 concentrations were higher in patients with AD than controls (adjusted for sLR11 using phospholipid). N–2DGE analysis showed that sLR11 and Aβ comigrated with a large apoE-containing CSF–HDL. Moreover, fewer apoE was bound to Aβ when a higher amount of apoE was bound to sLR11 in patients with AD who presented with ε4/4.ConclusionsLR11 binds to CSF–HDL and competes with Aβ in binding to apoE in CSF–HDL, indicating that sLR11 affects Aβ clearance via CSF–HDL.